PMC:7696151 / 41096-41349
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1149 | 58-68 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1158 | 29-32 | Chemical | denotes | HCQ | MESH:D006886 |
| 1163 | 237-252 | Disease | denotes | QT prolongation | MESH:D008133 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T265 | 0-253 | Sentence | denotes | Thus, the ineffectiveness of HCQ antiviral activity again SARS-CoV-2 can be related to the low current dosing regimens and the impossibility to increase the administered doses due to the increased risk of severe side effects, especially QT prolongation. |